High-level expression, purification, crystallization and preliminary X-ray crystallographic studies of the receptor-binding domain of botulinum neurotoxin serotype D (original ) (raw )High‐resolution crystal structures of the botulinum neurotoxin binding domains from subtypes A5 and A6
Amy Britton
FEBS Open Bio, 2020
View PDFchevron_right
Structural analysis of the receptor binding domain of botulinum neurotoxin serotype D
Howard Robinson
Biochemical and Biophysical Research Communications, 2010
View PDFchevron_right
Crystal structure of the receptor binding domain of the botulinum C–D mosaic neurotoxin reveals potential roles of lysines 1118 and 1136 in membrane interactions
Howard Robinson
Biochemical and Biophysical Research Communications, 2011
View PDFchevron_right
Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co‐receptor ganglioside
Kyle Gregory
FEBS Open Bio, 2020
View PDFchevron_right
Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding
Robert Gustafsson
Toxins
View PDFchevron_right
Crystal Structure of Botulinum Neurotoxin Type A in Complex with the Cell Surface Co-Receptor GT1b—Insight into the Toxin–Neuron Interaction
Pål Stenmark
PLoS Pathogens, 2008
View PDFchevron_right
The C Terminus of the Catalytic Domain of Type A Botulinum Neurotoxin May Facilitate Product Release from the Active Site
Robert Webb
Journal of Biological Chemistry, 2013
View PDFchevron_right
Expression, purification and comparative characterisation of enzymatically deactivated recombinant botulinum neurotoxin type A
Thuan phan van
The Botulinum J., 2008
View PDFchevron_right
Crystal Structure of the Botulinum Neurotoxin Type G Binding Domain: Insight into Cell Surface Binding
Pål Stenmark
Journal of Molecular Biology, 2010
View PDFchevron_right
Crystal Structures of Botulinum Neurotoxin Subtypes A4 and A5 Cell Binding Domains in Complex with Receptor Ganglioside
Kyle Gregory
Toxins, 2022
View PDFchevron_right
Production and characterization of a recombinant chimeric antigen consisting botulinum neurotoxin serotypes A, B and E binding subdomains
Valiollah Babaeipour
The Journal of toxicological sciences, 2010
View PDFchevron_right
Cloning, Expression, and One-Step Purification of the Minimal Essential Domain of the Light Chain of Botulinum Neurotoxin Type A
Bernhard Rupp
Protein Expression and Purification, 2000
View PDFchevron_right
Exchange of the HCC domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin
Andreas Rummel
FEBS Journal, 2011
View PDFchevron_right
High Yield Preparation of Functionally Active Catalytic-Translocation Domain Module of Botulinum Neurotoxin Type A That Exhibits Uniquely Different Enzyme Kinetics
Bal R Singh
The protein journal, 2017
View PDFchevron_right
Epitope Characterization and Variable Region Sequence of F1-40, a High-Affinity Monoclonal Antibody to Botulinum Neurotoxin Type A (Hall Strain)
Larry Stanker
PLoS ONE, 2009
View PDFchevron_right
Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity
Andreas Rummel , Thomas Binz
Nature, 2006
View PDFchevron_right
Separation of the components of type A botulinum neurotoxin complex by electrophoresis
Muhammad Bal
Toxicon, 2003
View PDFchevron_right
Molecular assembly of botulinum neurotoxin progenitor complexes
Nancy Shine
Proceedings of the National Academy of Sciences, 2013
View PDFchevron_right
Conformational sampling of the botulinum neurotoxin serotype a light chain: implications for inhibitor binding
krishna panchal
Bioorganic & Medicinal Chemistry, 2005
View PDFchevron_right
Protein Domain Analysis of C. botulinum Type A Neurotoxin and Its Relationship with Other Botulinum Serotypes
Uma Basavanna
2010
View PDFchevron_right
A Comprehensive Structural Analysis of Clostridium botulinum Neurotoxin A Cell-Binding Domain from Different Subtypes
Kyle Gregory
Toxins
View PDFchevron_right
Botulinum neurotoxin: unique folding of enzyme domain of the most-poisonous poison
Valeri Barsegov
Journal of Biomolecular Structure and Dynamics, 2014
View PDFchevron_right
The Botulinum Neurotoxin Complex and the Role of Ancillary Proteins
Bal R Singh
Molecular Aspects of Botulinum Neurotoxin, 2014
View PDFchevron_right
Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms
Flora Chen
Infection and Immunity, 1997
View PDFchevron_right
Dichain Structure of Botulinum Neurotoxin: Identification of Cleavage Sites in Types C, D, and F Neurotoxin Molecules
Hirokazu Kouguchi
Journal of Protein Chemistry, 1999
View PDFchevron_right
Molecular topography and secondary structure comparisons of botulinum neurotoxin types A, B and E
Bal R Singh
Molecular and Cellular Biochemistry, 1989
View PDFchevron_right
Expression and purification of catalytic domain of botulinum neurotoxin serotype ‘F’: immunological characterization and its application in detection
Shiv Yadav
Food Biotechnology, 2020
View PDFchevron_right
A historical and proteomic analysis of botulinum neurotoxin type/G
Adrian Woolfitt
BMC Microbiology, 2011
View PDFchevron_right
A novel role of C-terminus in introducing a functionally flexible structure critical for the biological activity of botulinum neurotoxin
Bal R Singh
Scientific reports, 2018
View PDFchevron_right
Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept
Andreas Rummel , Thomas Binz
Proceedings of the National Academy of Sciences, 2007
View PDFchevron_right